Ergoteles’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,600
| Closed | -$70.9K | – | 183 |
|
|
2023
Q2 | $70.9K | Buy |
+16,600
| New | +$70.9K | ﹤0.01% | 937 |
|
|
2022
Q2 | – | Sell |
-44,704
| Closed | -$577K | – | 1677 |
|
|
2022
Q1 | $577K | Buy |
44,704
+4,687
| +12% | +$60.5K | 0.02% | 617 |
|
|
2021
Q4 | $639K | Buy |
40,017
+26,417
| +194% | +$422K | 0.02% | 551 |
|
|
2021
Q3 | $219K | Buy |
+13,600
| New | +$219K | 0.01% | 938 |
|